Biological roles of carboxymethyl-chitin associated for the growth factor production

Journal of Biomedical Materials Research - Part A

Volumn 83, Issue 1, 2007, Pages 58-63

  Kariya, Hiroyuki ^a   Kiyohara, Ai ^a   Masuda, Shingo ^b   Yoshihara, Yusuke ^b   Ueno, Masaru ^b   Hashimoto, Masahito ^a   Suda, Yasuo ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Japan Medical Materials Corporation   (Japan)

Author keywords

Cartilage; Chitin; Inflammatory; Mononuclear cell; TGF

Indexed keywords

BIOASSAY; CARTILAGE; ENZYMES; GROWTH KINETICS;

CHONDROGENESIS; GROWTH FACTOR; IMMUNOSORBANT ASSAY; INFLAMMATORY CYTOKINES; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; THERAPEUTIC MATERIALS;

CHITIN;

CHEMOKINE; CHITIN; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHONDROGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL FRACTIONATION; CHITIN; CYTOKINES; EXUDATES AND TRANSUDATES; GELS; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; PERITONEUM; RNA, MESSENGER; SOLUBILITY; TIME FACTORS;

EID: 34548713517     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31202     Document Type: Article

References (51)

1. Shapiro F, Koide S, Glimcher MJ. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 1993;75:532-553.
2. Oka M. Biomechanics and repair of articular cartilage. J Orthop Sci 2001;6:448-456.
3. Minas T, Nehrer S. Current concepts in the treatment of articular cartilage defects. Orthopedics 1997;2:525-538.
4. Ponticiello MS, Schinagl RM, Kadiyala S, Barry FP. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J Biomed Mater Res 2000;52:246-255.
5. Ochi M, Adachi N, Nobuto H, Yanada S, Ito Y, Agung M. Articular cartilage repair using tissue engineering technique - Novel approach with minimally invasive procedure. Artif Organs 2004;28:28-32.
6. Britberg M, Lindahl A, Nilsson A, Ohlssion C, Isaksson O, Peterson C. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-895.
7. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem ells and cell-based tissue engineering. Arthritis Res Ther 2003;5:32-45.
8. Erggelet C, Steinwachs MR, Reichelt A. The operative treatment of full thickness cartilage defects in the knee joint with autologous chondrocyte transplantation. Saudi Med J 2000;21:715-721.
9. Kim UJ, Park J, Kim HJ, Wada M, Kaplan DL. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 2005;26:2775-2785.
10. Wang Y, Kim UJ, Blasioli DJ, Kim HJ, Kaplan DL. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells. Biomaterials 2005;26:7082-7094.
11. Chiroff RT, White RA, White EW, Weber JN, Roy D. The restoration of the articular surfaces overlying Replamineform porous biomaterials. J Biomed Mater Res 1977;11:165-178.
12. Suominen E, Aho AJ, Vedel E, Kangasniemi I, Uusipaikka E, Yli-Urpo A. Subchondral bone and cartilage repair with bioactive glasses, hydroxyapatite, and hydroxyapatite-glass composite. J Biomed Mater Res 1996;32:543-551.
13. Hasegawa M, Sudo A, Shikinami Y, Uchida A. Biological performance of a three-dimensional fabric as artificial cartilage in the repair of large osteochondral defects in rabbit. Biomaterials 1999;20:1969-1975.
14. Masuda S, Yoshihara Y, Muramatsu K, Wakebe I. Repairing of osteochondral defects in joint using β-TCP/carboxymethyl chitin composite. Key Eng Mater 2005;284-286:791-794.
15. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005;26:599-609.
16. Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. J Bone Miner Res 2002;17:513-520.
17. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;88:873-884.
18. Tokura S, Nishi N, Tsutsumi A, Somorin O. Studies on chitin. VIII. Some properties of water soluble chitin Derivatives. Polym J 1983;15:485-489.
19. Montgomery RA, Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991;147:554-560.
20. Ehlers S, Mielke ME, Blankenstein T, Hahn H. Kinetic analysis of cytokine gene expression in the livers of naïve and immune mice infected with Listeria monocytogenes. J Immunol 1992;149:3016-3022.
21. Souto JT, Aliberti JC, Campanelli AP, Livonesi MC, Maffei CML, Ferreira BR, Travassos LR, Martinez R, Rossi MA, Silva JS. Chemokine production and leukocyte recruitment to the lungs of Paracoccidioides brasiliensis-infected mice is modulated by interferon-γ. Am J Pathol 2003;163:583-590.
22. Wilson SE, Moban RR, Netto M, Perez V, Possin D, Huang J, Kwon R, Alekseev A, Rodriguez-Perez JP. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Invest Ophthalmol 2004;45:2201-2211.
23. Hatakeyama J, Sreenath T, Hatakeyama Y, Thyagarajan T, Shum L, Gibson CW, Wright JT, Kulkarni AB. The receptor activator of nuclear factor-κB ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice. J Biol Chem 2003;278:35743-35748.
24. Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999;72:2415-2425.
25. Kakiuchi M, Tsujigiwa H, Orita Y, Nagatsuka H, Yoshinobu J, Kariya S, Haginomori S, Orita S. Fukushima K, Okano M, Nagai N, Nishizaki K. Cyclooxygenase 2 expression in otitis media with effusion. Am J Otolaryngol 2006;27:81-85.
26. Brandau O, Aszodi A, Hunziker EB, Neame PJ, Vestweber D, Fassler R. Chondromodulin I is dispensable during enchondral ossification and eye development. Mol Cell Biol 2002;22:6627-6635.
27. Matsumura I, Kirsch JF. Is aspartate 52 essential for catalysis by chicken egg white lysozyme? The role of natural substrate-assisted hydrolysis. Biochemistry 1996;35:1881-1889.
28. Wan ACA, Khor E, Wong JM, Hasting GW. Promotion of calcification on carboxymethylchitin discs. Biomaterials 1996;17:1529-1534.
29. Muramatsu K, Nakajima M, Kikuchi M, Shimada S, Sasaki K, Masuda S, Yoshihara Y. In vitro cytocompatibility assessment of β-tricalcium phosphate/carboxymethyl-chitin composite. J Biomed Mater Res A 2004;71:635-643.
30. Harada Y, Wang JT, Doppalapudi VA, Willis AA, Jasty M, Harris WH, Nagase M, Goldring SR. Differential effects of different forms of hydroxyapatite and hydroxyapatite/tricalcium phosphate particulates on human monocyte/macrophages in vitro. J Biomed Mater Res 1996;31:19-26.
31. Park JE, Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg 2004;187:11S-16S.
32. Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin Exp Immunol 1993;93:206-211.
33. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor α interleukin-1β interleukin-8, and interleukin-1 receptor antagonist in monosodium urea crystal-induced rabbit arthritis. Lab Invest 1998;78:559-569.
34. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001;78:57-110.
35. Wahl SM, Costa GC, Mizel DE, Allen JB, Skaleric U, Mangan DF. Role of transforming growth factor β in the pathophysiology of chronic inflammation. J Periodontol 1993;64:450-455.
36. Yoshie O, Imai T, Nomiyama H. Chemokines in immunity. Adv Immunol 2001;78:57-110.
37. Ignotz RA, Massagues J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
38. Gunther M, Haubeck HD, van de Leur E, Blaser J, Bender S, Gutgemann I, Fischer DC, Tschesche H, Greiling H, Heinrich PC. Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum 1994;37:395-405.
39. Lum ZP, Hakala BE, Mort JS, Recklies AD. Modulation of the catabolic effects of interleukin-1β on human articular chondrocytes by transforming growth factor-β. J Cell Physiol 1996;166:351-359.
40. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989;264:1860-1869.
41. Bassols A, Massague J. Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988;263:3039-3045.
42. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 1989;264:380-388.
43. Ignotz RA, Heino J, Massague J. Regulation of cell adhesion receptors by transforming growth factor-β. Regulation of vitronectin receptor and LFA-1. J Biol Chem 1989;264:389-392.
44. Wahl SM, Allen JB, Weeks BS, Wong HL, Klotman PE. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993;90:4577-4581.
45. Schmitt B, Ringe J, Haupl T, Notter M, Manz R, Burmester G-R, Sittinger M, Kaps C. BMP2 initiates chondrogenic line-age development of adult human mesenchymal stem cells in high-density culture. Differentiation 2003;71:567-577.
46. Bai X, Xiao Z, Pan Y, Hu J, Pohl J, Wen J, Li L. Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchmal stem cells into chondrocytes. Biochem Biophys Res Commun 2004;325:453-460.
47. Champagne CM, Takebe J, Offnbacher S, Cooper LF. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone 2002;30:26-31.
48. Chen CW, Tsai YH, Deng WP, Shih SN, Fang CL, Burch JG, Chen WH, Lai WF. Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res 2005;23:446-453.
49. Sellers RS, Zhang R, Glasson SS, Kim HD, Peluso D, D'Augnsta DA, Beckwith K, Morris EA. Repair of articular cartilage defect one year after treatment with recombinant human bone morphogenetic protein-2 (BMP-2). J Bone Joint Surg Am 2000;82:151-160.
50. Cook SD, Patron P, Salkeld SL, Rueger DC. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am 2003;85:116-123.
51. Park H, Temenoff JS, Holland TA, Tabata T, Mikos AG. Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005;26:7095-7103.